U.S. Scar Treatment Market to 2023 by Type of Treatment, Type of Scar & End User - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 8, 2018--The “U.S. Scar Treatment Market by Type of Treatment, by Type of Scar, by End User - Market Size, Share, Development, Growth, and Demand Forecast, 2013 - 2023” report has been added to ResearchAndMarkets.com’s offering.
Global scar treatment market size is expected to reach $34.9 billion by 2023,
The market is mainly driven by rising prevalence of skin diseases, technological advancements in dermatological devices, rise in the number of road accidents, increasing number of surgical procedures performed, increasing awareness among people about various scar treatments, and surge in disposable income of general population leading to rise in spending on personal care.
Globally, North America accounted for the largest share of the scar treatment market, with 38.5% share in 2017. This is attributable to high disposable income of general population in the region, which further increases spending on personal care products. Moreover, the increasing appearance consciousness among the North American population has also led to rise in the adoption of technologically advanced products.
Key Topics Covered:
Chapter 1. Research Background
Chapter 2. Research Methodology
Chapter 3. Executive Summary
Chapter 4. Introduction
Chapter 5. Global Market Size And Forecast
Chapter 6. North America Market Size And Forecast
Chapter 7. Europe Market Size And Forecast
Chapter 8. APAC Market Size And Forecast
Chapter 9. LATAM Market Size And Forecast
Chapter 10. Mea Market Size And Forecast
Chapter 11. Competitive Landscape
Chapter 12. Company ProfilesHologic Inc. Syneron Medical Ltd. Beijing Toplaser Technology Company Limited Avita Medical Limited Mlnlycke Health Care Ab Shanghai Fosun Pharmaceutical (Group) Co. Ltd. Smith & Nephew Plc Revitol Corporation Inc. Sonoma Pharmaceuticals Inc. Cca Industries Inc. Scarguard Labs Llc Quantum Health Valeant Pharmaceuticals International Inc. Pacific World Corporation Merz Pharma Gmbh & Co. Kgaa Johnson & Johnson
For more information about this report visit https://www.researchandmarkets.com/research/4mh586/u_s_scar?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180808005626/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Dermatological Drugs
KEYWORD: UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/08/2018 01:47 PM/DISC: 08/08/2018 01:47 PM